Cahill Financial Advisors’s AbbVie ABBV Stock Holding History

Cahill Financial Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$693K	Buy	2,753 +62	+2%	+$13.3K	0.07%	157
2026 Q1	$585K	Sell	2,691 -18	-0.7%	-$3.99K	0.06%	163
2025 Q4	$619K	Sell	2,709 -337	-11%	-$76.8K	0.07%	154
2025 Q3	$705K	Buy	3,046 +231	+8%	+$47K	0.08%	150
2025 Q2	$523K	Sell	2,815 -164	-6%	-$30.5K	0.06%	165
2025 Q1	$624K	Buy	2,979 +160	+6%	+$31.1K	0.08%	145
2024 Q4	$501K	Buy	+2,819	New	+$518K	0.07%	163
2021 Q4	–	Sell	-113	Closed	-$12K	–	219
2021 Q3	$12K	Buy	+113	New	+$12.9K	﹤0.01%	516

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Cahill Financial Advisors's ABBV Position: Q2 2026 in Review

Cahill Financial Advisors increased its AbbVie (ABBV) stake by 2.3% in Q2 2026, buying an estimated $13.3K and bringing the position to 2,753 shares worth $693K. The position accounts for 0.07% of the portfolio, ranked #157.

Cahill Financial Advisors first reported a position in ABBV in Q3 2021 and has held it in 8 quarters since. The position peaked at $705K in Q3 2025. 4,232 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Cahill Financial Advisors held 2,753 shares of AbbVie worth $693K as of Q2 2026.
Cahill Financial Advisors bought 62 AbbVie shares in Q2 2026, an estimated $13.3K.
AbbVie made up 0.07% of Cahill Financial Advisors's portfolio in Q2 2026, its #157 holding.
Cahill Financial Advisors first reported a position in AbbVie in Q3 2021 and has held it in 8 quarters since.
Cahill Financial Advisors's AbbVie position peaked at $705K in Q3 2025.
4,232 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Cahill Financial Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.